Cognitive skills can change over time in MS, but the way we measure them needs improvement.
The study looked at how well people with secondary progressive MS (SPMS) could think and remember over 96 weeks. They found that some test scores, like the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT), improved a little, showing that people got better at these tasks even without treatment. However, other tests didn't show any consistent changes, suggesting that thinking skills may not always improve in MS patients. Also, brain scans showed that brain size decreased over time, which is common in MS. These findings indicate that we need better ways to measure changes in thinking skills, especially as people with chronic conditions like MS often don’t see improvements.
MS patients and their caregivers should care about these findings because they highlight how important it is to track changes in thinking and memory for better care. If tests show improvement, it can give hope and help patients feel more confident in their abilities. Understanding that brain size may decrease over time helps explain why some might struggle with memory or thinking tasks. Caregivers can use this information to support and encourage their loved ones by focusing on strengths and improvements noted in certain tests. Overall, this research can guide healthcare providers in finding better ways to help MS patients manage cognitive challenges.
The study had some limitations, such as not finding significant differences between treatment groups, which means we can't say for sure if one treatment is better than another for cognitive change. Also, it shows that while some tests improved, it doesn't mean that thinking skills are truly getting better over time for MS patients. Lastly, the decline in brain volume is an important sign that needs to be considered when looking at these results.
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More5/1/2026
Study finds CD29 marks blood B cells that can enter the brain and become antibody-producing cells in
Read More5/1/2026
Study finds early detection, lower spinal fluid virus, and PML‑IRIS relate to better 1‑year outcomes
Read More5/1/2026
Study found fewer hospital diagnoses of antibody-positive autoimmune encephalitis during COVID-19, b
Read More3/1/2026
Study shows C5 inhibitors given during or soon after NMOSD attacks helped most patients stabilize or
Read More3/1/2026
Early OCT eye scans can often distinguish MOGAD from NMOSD optic neuritis, helping guide faster trea
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.